GTIHNONCT07540611
Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive
StatusNot Yet Recruiting
PhaseNot applicable
SponsorIndira IVF Hospital Pvt Ltd
Primary completion (estimated)
At risk: Primary completion moved 10 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jan 16, 2027 to Nov 16, 2027 Show 5 more changesShow less
- Start date: Jul 17, 2026 to Jan 17, 2027
- Eligibility criteria shortened, about 28 words
- Study completion pushed from Jul 17, 2027 to Jun 17, 2028
- Secondary endpoints: details revised at 2 of 10 entries
- Publications: details revised at 3 of 3 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Success or Sperm Availability
Timeframe: from randomization through Week 16 via ejaculate or micro-TESE
Secondary (10)
Micro-TESE Sperm Retrieval Rate (SSR)
Need for Micro-TESE Surgery
Safety / Harms
ICSI Fertilization Rate
Blastulation Rate
Show 5 moreShow less
Blastocyst Quality
Top-Quality Blastocyst Rate
Clinical Pregnancy Rate
Miscarriage Rate
Live Birth
Arms and interventions
hCG + FSH therapyExperimental
Standard of CareActive comparator
Other: No intervention, hCG + FSH therapy
Sites
8 sites in 1 country